Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ionic Bonds00:42

Ionic Bonds

127.0K
Overview
When atoms gain or lose electrons to achieve a more stable electron configuration they form ions. Ionic bonds are electrostatic attractions between ions with opposite charges. Ionic compounds are rigid and brittle when solid and may dissociate into their constituent ions in water. Covalent compounds, by contrast, remain intact unless a chemical reaction breaks them.
Opposing Charges Hold Ions Together in Ionic Compounds
Ionic bonds are reversible electrostatic interactions between ions...
127.0K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

513
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
513
Introduction to Electrolytes01:33

Introduction to Electrolytes

14.8K
In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
14.8K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

2.5K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.5K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

513
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
513
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

1.4K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.

Cancer gene therapy·2026
Same author

Irisin treatment counteracts bone loss and muscle atrophy in aged mice by reducing sclerostin expression in bone and skeletal muscle.

Journal of translational medicine·2026
Same author

Erratum to Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy.

The Journal of clinical investigation·2026
Same author

A case of early pregnancy pulmonary embolism following mifepristone administration: a call for increased pharmacovigilance and research.

Blood transfusion = Trasfusione del sangue·2026
Same author

Sudden bilateral ocular pain, conjunctival redness and blurred vision with halos at hemodialysis start: an eye of attention for the nephrologist! Lessons for the Clinical Nephrologist.

Journal of nephrology·2026
Same author

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Blood·2026

Related Experiment Video

Updated: Dec 19, 2025

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.5K

Electrolyte Disorders Induced by Antineoplastic Drugs.

Ignazio Verzicco1, Giuseppe Regolisti2, Federico Quaini3

  • 1Unità di Ricerca Cardiorenale, Clinica e Terapia Medica, Dipartimento di Medicina e Chirurgia (DIMEC), University of Parma, Parma, Italy.

Frontiers in Oncology
|June 9, 2020
PubMed
Summary

Cancer treatments like antineoplastic drugs can cause dangerous electrolyte imbalances. This review details how chemotherapy affects sodium, potassium, magnesium, calcium, and phosphate levels, aiding clinical awareness and management.

Keywords:
antidiuretic hormone (ADH)antineoplastic drug exposureelectrolytes abnormalitiesrenal tubulopathiestumor lysis syndrome

More Related Videos

Electrochemotherapy of Tumours
03:57

Electrochemotherapy of Tumours

Published on: December 15, 2008

24.9K
Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.7K

Related Experiment Videos

Last Updated: Dec 19, 2025

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.5K
Electrochemotherapy of Tumours
03:57

Electrochemotherapy of Tumours

Published on: December 15, 2008

24.9K
Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.7K

Area of Science:

  • Oncology
  • Nephrology
  • Endocrinology

Background:

  • Antineoplastic drugs are crucial for cancer treatment but frequently cause electrolyte disturbances.
  • These derangements can lead to severe complications, including kidney injury and altered water balance.

Purpose of the Study:

  • To review the mechanisms of electrolyte and water balance disturbances induced by antineoplastic therapies.
  • To highlight the specific electrolyte abnormalities associated with various classes of anti-cancer agents.

Main Methods:

  • Literature review focusing on antineoplastic drug mechanisms and electrolyte metabolism.
  • Categorization of electrolyte disturbances based on drug class (platinum compounds, alkylating agents, Vinca alkaloids, targeted therapies).

Main Results:

  • Platinum compounds cause sodium, potassium, and magnesium issues.
  • Alkylating agents and Vinca alkaloids can lead to hyponatremia via SIADH.
  • Targeted therapies and anti-EGFR antibodies induce hyponatremia, sodium loss, and magnesium/potassium depletion.
  • Tumor lysis syndrome results in hyperphosphatemia, hypocalcemia, and hyperkalemia.

Conclusions:

  • Clinicians must recognize chemotherapy-induced electrolyte imbalances.
  • Awareness enables preventive strategies and timely treatment for better patient outcomes.